Cholesterol Subfraction Analysis in Patients with Acute Coronary Syndrome

被引:11
作者
Kidawa, Michal [1 ]
Gluba-Brzozka, Anna [2 ]
Zielinska, Marzenna [1 ]
Franczyk, Beata [3 ]
Banach, Maciej [4 ]
Rysz, Jacek [3 ]
机构
[1] Med Univ Lodz, Dept Intens Cardiac Therapy, Cent Teaching Hosp, Lodz, Poland
[2] WAM Teaching Hosp, Dept Nephrol Hypertens & Family Med, Zeromskiego 113, PL-90549 Lodz, Poland
[3] Med Univ Lodz, Dept Nephrol Hypertens & Family Med, Lodz, Poland
[4] Med Univ Lodz, Dept Hypertens, Lodz, Poland
关键词
Acute coronary syndrome; HDL subfractions; LDL subfractions; diabetes mellitus; restenosis; atherosclerosis; ACUTE MYOCARDIAL-INFARCTION; LIPOPROTEIN LDL SUBCLASSES; HIGH-DENSITY-LIPOPROTEIN; ST-SEGMENT ELEVATION; ARTERY-DISEASE; CARDIOVASCULAR-DISEASE; CLINICAL-SIGNIFICANCE; DIABETES-MELLITUS; EUROPEAN-SOCIETY; ASSOCIATION;
D O I
10.2174/1570161116666180601083225
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: There is a close relationship between lipid metabolism disorders and atherosclerosis. Guidelines focus on lowering Low-Density Lipoprotein Cholesterol (LDL-C) levels. However, it should be kept in mind that LDL and High-Density Lipoprotein (HDL) consist of subfractions which can affect the progression of atherosclerosis. Objective: We assessed the concentration of LDL and HDL subfractions in patients with Acute Coronary Syndromes (ACS). The influence of the presence of type 2 diabetes mellitus on LDL and HDL subfractions was also analyzed. Methods: The study group consisted of 127 patients (62 men, 65 women) with ACS. All patients had coronary angiography and coronary angioplasty and stenting when necessary. Medical history was collected during 12 months of follow-up. HDL and LDL subfraction distribution was measured using Lipoprint (Quantimetrix). Results: No differences in LDL nor HDL subfractions were observed between ST-Segment Elevation Myocardial Infarction (STEMI), Non-ST-Segment Elevation Myocardial Infarction (NSTEMI) and unstable angina (UA) patients. However, those with restenosis and the necessity of repeated revascularization had higher levels of intermediate-density lipoprotein C (IDL-C) (p=0.055) and LDL3 (p=0.048) as compared with the patients without, while the level of IDL A (IDLA) was lower than in the latter group (p=0.036). In diabetic patients, the percentage share of HDL10 and small-dense HDL was significantly higher while the share of HDL1 (small-dense) (p=0.028), HDL4 (intermediate density) (p=0.052) and HDL5 (intermediate density) (p=0.060) were lower than in patients without DM. Conclusion: Patients with multi-vessel CAD disease had higher levels of LDL3 subfraction and IDL-C and a lower proportion of IDLA.
引用
收藏
页码:365 / 375
页数:11
相关论文
共 53 条
  • [1] Effect of diabetes mellitus on formation of coronary collateral vessels
    Abaci, A
    Oguzhan, A
    Kahraman, S
    Eryol, NK
    Ünal, S
    Arinç, H
    Ergin, A
    [J]. CIRCULATION, 1999, 99 (17) : 2239 - 2242
  • [2] [Anonymous], 2019, DIABETES CARE, V42, pS1, DOI [10.2337/dc20-Sint, 10.2337/dc19-Sint01, 10.2337/dc19-SINT01, 10.2337/dc16-S001, 10.2337/dc20-SINT]
  • [3] [Anonymous], JSM ATHEROSCLER
  • [4] [Anonymous], J JPN CORON ASS
  • [5] [Anonymous], ANN NONINVASIVE ELEC
  • [6] [Anonymous], AM J GERIATR CARDIOL
  • [7] [Anonymous], J AM COLL CARDIOL S
  • [8] Bassand JP, 2007, EUR HEART J, V28, P1598, DOI 10.1093/eurheartj/ehm161
  • [9] Coronary risk factors and plaque morphology in men with coronary disease who died suddenly
    Burke, AP
    Farb, A
    Malcom, GT
    Liang, YH
    Smialek, J
    Virmani, R
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (18) : 1276 - 1282
  • [10] Heart failure with systolic dysfunction complicating acute myocardial infarction - differential outcomes but similar eplerenone efficacy by ST-segment or non-ST-segment elevation: A post hoc substudy of the EPHESUS trial
    Carillo, Sylvain
    Zhang, Yan
    Fay, Renaud
    Angioi, Michael
    Vincent, John
    Sutradhor, Santosh C.
    Ahmed, Ali
    Pitt, Bertram
    Zannad, Faiez
    [J]. ARCHIVES OF CARDIOVASCULAR DISEASES, 2014, 107 (03) : 149 - 157